| Particulars |
| Company Name |
Aurobindo Pharma Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
58.59 |
B.V. Rs |
350.50 |
| Sales Rs Cr. |
10,933.30 |
NP Rs Cr. |
1,741.31 |
| NP Var% |
-11.00 |
Div% |
0.00 |
| CPS Rs |
34.80 |
EPS Rs |
29.70 |
| Traded Value(Rs Lakhs) |
899.41 |
52 Week High |
1,560.00 |
| 52 Week Low |
994.00 |
Price BSE |
1,129.00 |
| Price NSE |
1,129.00 |
Market Capital(Rs Cr.) |
66,123.17 |
| P/C Ratio |
32.50 |
P/E Ratio |
38.00 |
| Price Vs.BV |
3.22 |
|
| Latest Quarter |
| Year End |
202506 |
Sales Rs Cr. |
2,822.14 |
| NP Rs Cr. |
559.13 |
NP Var % |
70.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
10,713.37 |
| OPM |
23.11 |
NP |
2,069.02 |
| NP Var% |
3.44 |
EPS |
33.74 |
| PE |
33.45 |
|
|